Serum Institute To Invest 240 Million Pounds In UK
New Delhi: Vaccine maker the Serum Institute of India is set to invest in facilities in the United Kingdom and could even manufacture inoculations in the UK in future.
This has been informed by British Prime Minister Boris Johnson.
Johnson’s Downing Street office said the 240 million Great British Pounds ($334 million) project would include a sales office, “clinical trials, research and development and possibly manufacturing of vaccines”.
SII has also begun phase one trials in the UK of a one-dose nasal vaccine for coronavirus.
Downing Street said the vaccine maker’s plans were part of a wider package of trade and investment deals with India worth $1 billion that it expects to create over 6,500 jobs.